Bruker (BRKR) Stock: Buy, Sell, or Hold?
BRKR - Bruker Corporation
$53.43
-0.13 (-0.24%)
▼
5d:
-10.07%
30d:
-9.85%
90d:
-3.17%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 02, 2026
Get Alerted When BRKR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BRKR is down 10.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BRKR is down 10.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$72.84
Based on 8.3% avg growth
INTRINSIC VALUE TODAY
$45.23
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BRKR is currently trading at $53.43, which is considered oversold relative to its 30-day fair value range of $54.03 to $59.81. The stock's valuation (Forward PE: 22.4) is in line with its historical norms (20.5). At these levels, the market is pricing in 2.9% annual earnings growth.
Technical Outlook: Technically, BRKR is in a strong uptrend. The price is currently testing key support at $52.58. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $59.23 (+10.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BRKR is in a strong uptrend. The price is currently testing key support at $52.58. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $59.23 (+10.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$54.03 -
$59.81
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.5%
Protect Your Profits
Holding BRKR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($59.23)
- BULLISH: Expecting earnings turnaround to 2.9% growth with 5.2% revenue growth
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$54.03 -
$59.81
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$52.58
Resistance Level
$60.29
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.36
Wall Street Target
$59.23
(+10.9%)
Revenue Growth (YoY)
5.2%
Earnings Growth (YoY)
-81.8%
Profit Margin
-2.0%
Valuation Premium vs History
+2.9% premium
PE vs Historical
22.4 vs 20.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.9%
(market-implied from PE analysis)
1-Year Target
$54.98
(+3%)
2-Year Target
$56.57
(+6%)
3-Year Target
$58.21
(+9%)
3-Yr Target (if PE normalizes)
(PE: 22→21)
PE COMPRESSION
$53.37
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 12.6%)
$76.26
(+43%)
Base:
(SPY PE: 20.2, Growth: 12.6%)
$68.79
(+29%)
Bear:
(PE: 17.1, Growth: 12.6%)
$58.47
(+9%)
Share & Embed Analysis
Last updated: September 12, 2026 12:59 PM ET
Data refreshes hourly during market hours. Next update: 1:59 PM
Data refreshes hourly during market hours. Next update: 1:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BRKR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark Munch
SELL
2000 shares
2026-04-15
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 41 HOLD |
Advanced BRKR Option Strategies
Professional options setups generated by AI based on today's BRKR price and gamma walls.
